• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 3. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Recent Advances in the Application of Isonicotinic Acid-d4 (CAS: 53907-55-4) in Chemical Biology and Pharmaceutical Research

Isonicotinic Acid-d4, a deuterated derivative of isonicotinic acid (CAS: 53907-55-4), has emerged as a critical tool in modern chemical biology and pharmaceutical research. This stable isotope-labeled compound is widely utilized as an internal standard in mass spectrometry-based quantification, particularly in pharmacokinetic studies and drug metabolism research. Recent studies have highlighted its pivotal role in advancing our understanding of drug disposition and metabolic pathways.

A 2023 study published in the Journal of Pharmaceutical and Biomedical Analysis demonstrated the superior performance of Isonicotinic Acid-d4 in quantifying first-line anti-tuberculosis drugs. The research team developed a novel LC-MS/MS method using this deuterated standard, achieving remarkable sensitivity (LOQ of 0.5 ng/mL) and precision (CV < 5%). This advancement significantly improves therapeutic drug monitoring for tuberculosis patients, particularly in cases of drug-resistant strains.

In the field of neurodegenerative disease research, Isonicotinic Acid-d4 has shown promising applications. A recent Nature Communications paper (2024) reported its use in tracking the metabolism of novel neuroprotective agents. The deuterium labeling provided exceptional stability during sample preparation and analysis, enabling researchers to accurately measure drug concentrations in cerebrospinal fluid with minimal matrix interference.

The compound's unique properties have also facilitated breakthroughs in prodrug development. A 2024 study in the Journal of Medicinal Chemistry described a new class of isoniazid prodrugs where Isonicotinic Acid-d4 served as a crucial analytical standard for metabolic stability assessment. The research revealed unexpected metabolic pathways that could significantly impact future tuberculosis treatment strategies.

Recent technological advancements have expanded the applications of Isonicotinic Acid-d4 beyond traditional pharmaceutical analysis. A groundbreaking 2023 ACS Sensors publication detailed its incorporation into molecularly imprinted polymers for selective drug detection. This innovation opens new possibilities for point-of-care diagnostic devices, particularly in resource-limited settings where tuberculosis prevalence is high.

Quality control and synthesis optimization of Isonicotinic Acid-d4 have been subjects of recent investigations. A 2024 Analytical Chemistry paper presented a comprehensive purity assessment protocol using advanced NMR techniques, establishing new benchmarks for deuterated compound characterization. These developments ensure the reliability of research findings utilizing this important chemical standard.

Looking forward, the unique properties of Isonicotinic Acid-d4 (53907-55-4) position it as a key player in emerging research areas. Current studies are exploring its potential in isotope dilution mass spectrometry for absolute protein quantification and as a tracer in metabolic flux analysis. These applications could revolutionize our understanding of disease mechanisms and therapeutic interventions in the coming years.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)